Cryoport, Inc.
CYRXIndustrialsNASDAQIntegrated Freight & Logistics · Last scanned Oct 26, 2026
Scan Results
Daily timeframePart of the industrials sector, Cryoport, Inc. (CYRX) is listed under Integrated Freight & Logistics. At a $910.7M market cap, Cryoport, Inc. ranks as a small-cap company within industrials. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.
Market Cap
$910.7M
Beta
1.96
P/E (TTM)
—
P/E (Fwd)
-27.11
EPS (TTM)
$-0.81
EPS (Fwd)
$-0.66
ROE
-6.5%
ROA
-2.4%
Cash
$396.7M
Total Debt
$232.0M
Free CF
-$14.7M
52W Change
72.9%
Annual Financials
Cash vs Debt
Where CYRX stands vs its 150-day and 200-day moving averages
As of the October 13, 2026 close, CYRX finished 21.15% above its 150-day moving average ($13.90) and 31.77% above its 200-day moving average ($12.78). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CYRX overbought or oversold?
At the October 13, 2026 close, CYRX's RSI(14) was 39.2, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $396.7M in cash comfortably exceeding the $232.0M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow is running at -$14.7M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -6.5%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $237.3M (2022) to $176.2M (2025), a 26% decline worth watching.
A beta of 1.96 means CYRX is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Cryoport, Inc.'s trajectory.